Glybera(TM) Shows Long-Term Health Benefits
AMSTERDAM, The Netherlands, June 18 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today new data showing that a one-time…